Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Melanoma

  Free Subscription


05.11.2018

1 Am J Ophthalmol
1 Am J Surg
1 Ann Surg Oncol
1 BMC Cancer
1 Cancer
1 Cancer Res
1 Cutis
2 Eur J Dermatol
1 J Cell Physiol
1 J Invest Dermatol
7 Melanoma Res
1 Nat Med
1 Oncogene
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Ophthalmol

  1. MCLEAN IW, Foster WD, Zimmerman LE, Gamel JW, et al
    Modifications of Callender's Classification of Uveal Melanoma at the Armed Forces Institute of Pathology.
    Am J Ophthalmol. 2018;195:lvi-lx.
    PubMed     Text format     Abstract available


    Am J Surg

  2. KIELHORN BA, Jantz JB, Kosten MS, Phillips SS, et al
    Quality improvement in melanoma care: Multidisciplinary quality program development and comparison of care before and after implementation.
    Am J Surg. 2018 Oct 17. pii: S0002-9610(18)30915.
    PubMed     Text format     Abstract available


    Ann Surg Oncol

  3. THOMPSON JF, Kroon HM
    ASO Author Reflections: Limited Surgery Plus Radiotherapy for Melanoma Patients with Cervical Node Metastases.
    Ann Surg Oncol. 2018 Oct 26. pii: 10.1245/s10434-018-6959.
    PubMed     Text format    


    BMC Cancer

  4. IIDA Y, Salomon MP, Hata K, Tran K, et al
    Predominance of triple wild-type and IGF2R mutations in mucosal melanomas.
    BMC Cancer. 2018;18:1054.
    PubMed     Text format     Abstract available


    Cancer

  5. BHATTY M, Kato S, Piha-Paul SA, Naing A, et al
    Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients With BRAF-mutated melanoma and other advanced malignancies.
    Cancer. 2018 Nov 1. doi: 10.1002/cncr.31812.
    PubMed     Text format     Abstract available


    Cancer Res

  6. CAUWELS A, Van Lint S, Paul F, Garcin G, et al
    Delivering Type I Interferon to Dendritic Cells Empowers Tumor Eradication and Immune Combination Treatments.
    Cancer Res. 2018;78:463-474.
    PubMed     Text format     Abstract available


    Cutis

  7. KONSTANTINOV NK, Berry TM, Elwood HR, Zlotoff BJ, et al
    Nevus of Ota associated with a primary uveal melanoma and intracranial melanoma metastasis.
    Cutis. 2018;102:E2-E4.
    PubMed     Text format     Abstract available


    Eur J Dermatol

  8. BEAUDOUX O, Riffaud L, Barbe C, Grange F, et al
    Prognostic factors and incidence of primary mucosal melanoma: a population-based study in France.
    Eur J Dermatol. 2018 Oct 30. pii: ejd.2018.3398. doi: 10.1684/ejd.2018.3398.
    PubMed     Text format     Abstract available

  9. BREGEON B, Nguyen JM, Varey E, Quereux G, et al
    Positive margins after surgical excision of locoregional cutaneous melanoma metastasis and their impact on patient outcome.
    Eur J Dermatol. 2018 Oct 30. pii: ejd.2018.3402. doi: 10.1684/ejd.2018.3402.
    PubMed     Text format     Abstract available


    J Cell Physiol

  10. GUO Y, Long J, Lei S
    Promoter methylation as biomarkers for diagnosis of melanoma: A systematic review and meta-analysis.
    J Cell Physiol. 2018 Oct 28. doi: 10.1002/jcp.27495.
    PubMed     Text format     Abstract available


    J Invest Dermatol

  11. OLSEN CM, Pandeya N, Thompson BS, Dusingize JC, et al
    Association between phenotypic characteristics and melanoma in a large prospective cohort study.
    J Invest Dermatol. 2018 Oct 24. pii: S0022-202X(18)32692.
    PubMed     Text format     Abstract available


    Melanoma Res

  12. VUJIC I, Gandini S, Stanganelli I, Fierro MT, et al
    A meta-analysis of melanoma risk in industrial workers.
    Melanoma Res. 2018 Oct 26. doi: 10.1097/CMR.0000000000000531.
    PubMed     Text format     Abstract available


  13. A unique gene expression signature is significantly differentially expressed in tumor-positive or tumor-negative sentinel lymph nodes in patients with melanoma: Erratum.
    Melanoma Res. 2018;28:655.
    PubMed     Text format    

  14. BUYUKKAPU BAY S, Kebudi R, Zulfikar B
    Cutaneous adverse event associated with vemurafenib in a 3-year-old pediatric patient with BRAF mutation-positive metastatic melanoma and factor X deficiency.
    Melanoma Res. 2018 Oct 29. doi: 10.1097/CMR.0000000000000537.
    PubMed     Text format     Abstract available

  15. DRAGO JZ, Lawrence D, Livingstone E, Zimmer L, et al
    Clinical experience with combination BRAF/MEK inhibitors for melanoma with brain metastases: a real-life multicenter study.
    Melanoma Res. 2018 Oct 29. doi: 10.1097/CMR.0000000000000527.
    PubMed     Text format     Abstract available

  16. ZHANG D, Wang Z, Shang D, Yu J, et al
    Incidence and prognosis of brain metastases in cutaneous melanoma patients: a population-based study.
    Melanoma Res. 2018 Oct 30. doi: 10.1097/CMR.0000000000000538.
    PubMed     Text format     Abstract available

  17. ABBOTT JL, Qureshi MM, Truong MT, Sahni D, et al
    Comparing survival outcomes in early stage desmoplastic melanoma with or without adjuvant radiation.
    Melanoma Res. 2018 Oct 31. doi: 10.1097/CMR.0000000000000532.
    PubMed     Text format     Abstract available

  18. PEPIN F, Julien AS, Fugaru I, Lihimdi N, et al
    Regression rate of choroidal melanoma following iodine-125 brachytherapy is not associated with metastatic spread.
    Melanoma Res. 2018 Oct 31. doi: 10.1097/CMR.0000000000000540.
    PubMed     Text format     Abstract available


    Nat Med

  19. CEREZO M, Guemiri R, Druillennec S, Girault I, et al
    Translational control of tumor immune escape via the eIF4F-STAT1-PD-L1 axis in melanoma.
    Nat Med. 2018 Oct 29. pii: 10.1038/s41591-018-0217.
    PubMed     Text format     Abstract available


    Oncogene

  20. WEI CY, Zhu MX, Lu NH, Peng R, et al
    Bioinformatics-based analysis reveals elevated MFSD12 as a key promoter of cell proliferation and a potential therapeutic target in melanoma.
    Oncogene. 2018 Nov 1. pii: 10.1038/s41388-018-0531.
    PubMed     Text format     Abstract available


    PLoS One

  21. BEHRENS G, Niedermaier T, Berneburg M, Schmid D, et al
    Physical activity, cardiorespiratory fitness and risk of cutaneous malignant melanoma: Systematic review and meta-analysis.
    PLoS One. 2018;13:e0206087.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: